- Home
- MOGU vs LPCN Comparison
MOGU vs LPCN Comparison
Compare MOGU & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- LPCN
- Stock Information
- Founded
- MOGU 2011
- LPCN 1997
- Country
- MOGU China
- LPCN United States
- Employees
- MOGU N/A
- LPCN N/A
- Industry
- MOGU Business Services
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- LPCN Health Care
- Exchange
- MOGU Nasdaq
- LPCN Nasdaq
- Market Cap
- MOGU 19.1M
- LPCN 16.1M
- IPO Year
- MOGU 2018
- LPCN N/A
- Fundamental
- Price
- MOGU $2.09
- LPCN $3.10
- Analyst Decision
- MOGU
- LPCN Strong Buy
- Analyst Count
- MOGU 0
- LPCN 1
- Target Price
- MOGU N/A
- LPCN $10.00
- AVG Volume (30 Days)
- MOGU 41.7K
- LPCN 10.3K
- Earning Date
- MOGU 11-22-2024
- LPCN 05-08-2025
- Dividend Yield
- MOGU N/A
- LPCN N/A
- EPS Growth
- MOGU N/A
- LPCN N/A
- EPS
- MOGU N/A
- LPCN N/A
- Revenue
- MOGU $19,801,126.00
- LPCN $11,198,144.00
- Revenue This Year
- MOGU N/A
- LPCN N/A
- Revenue Next Year
- MOGU N/A
- LPCN N/A
- P/E Ratio
- MOGU N/A
- LPCN N/A
- Revenue Growth
- MOGU N/A
- LPCN N/A
- 52 Week Low
- MOGU $1.75
- LPCN $2.75
- 52 Week High
- MOGU $3.58
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- MOGU 48.75
- LPCN 46.56
- Support Level
- MOGU $1.96
- LPCN $2.82
- Resistance Level
- MOGU $2.28
- LPCN $3.27
- Average True Range (ATR)
- MOGU 0.17
- LPCN 0.23
- MACD
- MOGU 0.00
- LPCN 0.01
- Stochastic Oscillator
- MOGU 48.89
- LPCN 58.92
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.